Diabetes Diagnostics: Market Research Report

Date: January 10, 2016
Pages: 429
Price:
US$ 4,950.00
Publisher: Global Industry Analysts, Inc
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: DBD21F18BE6EN
Leaflet:

Download PDF Leaflet

Diabetes Diagnostics: Market Research Report
This report analyzes the worldwide markets for Diabetes Diagnostics in US$ Thousand by the following Product Segments: Continuous Glucose Monitoring (CGM) Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022.

Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 58 companies including many key and niche players such as -
  • Abbott Diabetes Care, Inc.
  • Acon Laboratories, Inc.
  • AgaMatrix, Inc.
  • Alere Inc.
  • Animas Corporation
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Continuous Glucose Monitoring (CGM) Systems
HbA1c Testing Devices
Blood Glucose Monitoring Devices

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

Diabetes Diagnostics: Towards Easier, Economic, and Efficient Management of the Global Diabetes Epidemic
Evolution of Diabetes Testing over the Years with Key Features in Each Period
Growth Drivers in a Nutshell
Alarming Levels of Diabetes Incidence Worldwide Drives Strong Demand for Diabetes Diagnostic Devices

Table 1. Diabetes Prevalence Worldwide by Region: Number of Adults (20-79 Years) with Diabetes in 2015 and 2040 (includes corresponding Graph/Chart)
Table 2. Global Prevalence (%) of Diabetes in Adults (20-79) by Region: 2015 & 2040 (includes corresponding Graph/Chart)
Table 3. Global Prevalence of Diabetes by Gender (2015 & 2040): Number of Adults Diagnosed with Diabetes (in Million) for Men and Women (includes corresponding Graph/Chart)
Table 4. Worldwide Diabetes Prevalence (%) in Adults by Age Group and Gender: 2015 (includes corresponding Graph/Chart)
Table 5. Number of Adults with Diagnosed Diabetes in Urban and Rural Areas (2015 & 2040) (In Million) (includes corresponding Graph/Chart)
Table 6. Top 10 Countries with Highest Number of Adults Diagnosed with Diabetes (in Million) for 2015 & 2040 (includes corresponding Graph/Chart)

Diabetes: One of the Leading Causes of Death

Table 7. Proportion of Deaths on Account of Diabetes in People Aged Less than 60 Years by Region: 2015 (includes corresponding Graph/Chart)

Etiological Factors Causing Diabetes
Diabetes Incidence and Prevalence by Region/Country
North America
United States
Canada
Mexico
Europe
Asia-Pacific
Southeast Asian Region
Western Pacific Region
South & Central America
Africa
Global Market Outlook
Developing Countries Continue to Offer Significant Growth Opportunities
China: An Untapped Goldmine for Diabetes Diagnostic Devices
Rising Diabetic Populace Spurs Growth in the Indian Market

Table 8. Global Diabetes Diagnostics Market - Geographic Regions Ranked by CAGR (Value) for 2015-2022: China, India, Germany, UK, US, France, Italy, Russia, Spain, Canada, and Japan (includes corresponding Graph/Chart)

2. COMPETITION

Major Pharma Players Dominate Diabetes Diagnostics Market
Competition with Local Pharma Companies Intensifies in Regional Markets
Continuous Glucose Monitoring Systems (CGMS): Competitive Landscape

Table 9. Leading Products/Brands in the Global Continuous Glucose Monitoring Market (2015): Percentage Breakdown of Value Sales for Dexcom G4 Platinum, Dexcom Seven Plus, Free Style Navigator, Guardian Real Time, Minimed Paradigm Revel and Others (includes corresponding Graph/Chart)

Medtronic Dominates the Global CGM Devices Market
Leading Companies Continue to Focus on CGM Innovations
Leading Companies and their CGM Innovations
CGM Companies Outsmart Each Other with Innovative Marketing Offers
The Big Four in the Global Blood Glucose Monitoring (BGM) Devices Market

Table 10. Leading Players in the Global Blood Glucose Monitoring Devices Market (2015): Percentage Market Share Breakdown for Abbott, Bayer, LifeScan, Roche, and Others (includes corresponding Graph/Chart)

Quality Products at Low Prices: Mantra for Success in the Marketplace
After PDAs, SMBG Makers Turn to Mobile Devices to Woo Users on the Move
Competition in the HbA1c Testing Devices Market

Table 11. Leading Players in the Global HbA1c Reagent Market (2015E): Percentage Breakdown of Revenues for Siemens and Others (includes corresponding Graph/Chart)

Select Laboratory-based HbA1c Testing Products/Analyzers
Select Point of Care HbA1c Testing Products/Analyzers
Major POC HbA1c Tests in the Market
Select HbA1c POC Tests in the Market - A Comparison
Product Innovation is the Name of the Game for HbA1c Testing Device Companies
Manufacturers Focus on Offering Products for Developing Markets

3. MARKET TRENDS, ISSUES & DRIVERS

Growing Prominence of Real-Time Glucose Sensing and Monitoring Drive Robust Demand for Minimally-Invasive CGM Devices
CGM Market Gradually Breaks through Barriers to Adoption

Table 12. Penetration Rate (%) of CGM Devices in Type 1 and Type 2 Diabetes Market in the United States: 2013 through 2020 (includes corresponding Graph/Chart)

Intensive Care Units: A Highly Promising Market for CGMs
Proven Efficacy for Development of Intervention Strategies Drives Demand for HbA1c Testing Devices
Rising Popularity of Near Patient Testing Benefits Prospects for HbA1c Devices
Myriad Benefits of POC HbA1c Tests over Lab Tests Drives Widespread Adoption
Home HbA1c Testing: Lack of Reimbursement Coverage & Accuracy Concerns Affect Adoption
Glycated Albumin: A Potential Threat to HbA1c?
Approval for HbA1c Testing for Diabetes Diagnosis: An Opportunity to Tap
Is HbA1c Test Right in Being Recommended for Diagnostic Purposes?
HbA1c Tests for Diabetes Diagnosis Need to Address Issues Related to Hemoglobin Variants
ESC and ADA Release Revised Guidelines for HbA1c Testing
Despite Competition from CGM Systems and HbA1c Testing Devices, BGM Devices Continues to Dominate Sales
Cost: The Ultimate Factor Favoring Growth in Demand for Blood Glucose Monitoring Systems
Self-Monitoring/Household Blood Glucose: Sustaining Growth in Demand
Key Trends in the Glucose Meter/Monitoring Systems
Smartphone Penetration Favors SMBG Market

Table 13. Smartphone Penetration Rate (%) for Select Countries Worldwide as a Percentage of Population Owning a Phone: 2016 (includes corresponding Graph/Chart)

Demand for BGM Products to Witness Varying Patterns in Developed and Developing Markets
Barriers to Adoption of New Technology in BGM Products
Accuracy Issues Plague Blood Glucose Meters Market
Advancements in Glucose Monitoring Devices Offers a New Ray of Hope
Undiagnosed Diabetes: A Major Healthcare Challenge Offering Huge Untapped Potential

Table 14. Number of Undiagnosed Individuals (20-79 Years in Million) Living with Diabetes and Proportion (%) Worldwide by Region: 2015 (includes corresponding Graph/Chart)

Undiagnosed Diabetics: More Prone to Cardiovascular Diseases
Increased Vulnerability of Diabetics to Various Health Complications Boosts Demand for Diagnostic Devices
Heart Disease
Stroke
High Blood Pressure
Blindness
Kidney Disease
Nerve Disease
Amputations
Dental Disease
Pregnancy
Microvascular Complications (Small Blood Vessel Damage)
Retinopathy
Diabetic Neuropathy
Nephropathy
Macrovascular Complications (Large Blood Vessel Damage)
Cardiac Problems
Hypertension (High Blood Pressure)
Infections
Impotence
Pregnancy Complications
Other Complications Resulting from Diabetes
Obesity
Obsessive Compulsive Disorder
Foot Ulcers
Dementia
Hypoglycemia
Diabetic Ketoacidosis
Non-Insulin-Dependent Diabetes Mellitus (NIDDM) Lead to Cardiovascular Complications
High Risk of Diabetes in the Fast Expanding Aging Population Benefit Market Expansion
Demographic Statistics of the Global Aging Populace: Unfurling the Market Potential

Table 15. Global Aging Population (in Thousands) by Age Group: 1975-2050 (includes corresponding Graph/Chart)
Table 16. Global Population by Age-Group: Percentage Change Over the Period 2010-2050 (includes corresponding Graph/Chart)
Table 17. Global Aging Population in Select Regions/ Countries: Population of 60+ Individuals in ‘000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart)

Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis
Increasing Healthcare Expenditure Aids Diabetes Diagnostics & Testing Market

Table 18. Global Per Capita Healthcare Spending (in US$) by Geographic Region for the Year 2014 (includes corresponding Graph/Chart)
Table 19. Healthcare Spending as % of GDP by Geographic Region (2016E) (includes corresponding Graph/Chart)
Table 20. Top Countries with the Highest Per Capita Healthcare Spending (2014) (includes corresponding Graph/Chart)

Rising Expenditure on Diabetes Management Drives the Need for Timely Diagnosis and Diagnostic Devices

Table 21. Global Prevalence of Diabetes and Expenditure on its Management by Region (2015 & 2040P): Number of People Diagnosed with Diabetes in the Age Group 20-79 Years (Billions) and Expenditure on Management of Diabetes and its Complications (in US$ Billions) (includes corresponding Graph/Chart)
Table 22. Leading Countries by Health Expenditure on Diabetes (2015 & 2040) (in US$ Billion) (includes corresponding Graph/Chart)
Table 23. Expenditure on Diabetes in Adult (20-79) as % of Total Healthcare Spending by Region (2015) (includes corresponding Graph/Chart)
Table 24. Health Expenditure on Diabetes by Region: Average Diabetes-Related Spending per Person with Diabetes in US$ for 2015 (includes corresponding Graph/Chart)
Table 25. Health Expenditure on Diabetes (2015): Average Diabetes-Related Spending per Person with Diabetes (US$) in Select Countries (includes corresponding Graph/Chart)

Increasing Obesity Levels Underpins Market Growth

Table 26. Global Obesity Epidemic: Percentage of Overweight, Obese, and Severely Obese Adults for 2014 & 2025 (includes corresponding Graph/Chart)
Table 27. Severely Obese Population (in Thousands) Worldwide by Country: 2014 & 2025 (includes corresponding Graph/Chart)

4. DIABETES DIAGNOSTICS INNOVATIONS & ADVANCEMENTS

mHealth Solutions for Diabetes Diagnosis
Non-invasive Wearable Glucose Testing Devices
Apple and Google to Develop Wearable Continuous Glucose Monitors
GlySens Focus on Developing Implantable Continuous Glucose Monitor
Researchers Develop Prototype of Wearable Closed-Loop System
Glucovation SugarSenz: Cloud Enabled CGM Device
EyeSense to Develop Affordable CGM Device
Insulin Pump with CGM Sensor
Glucose Monitoring through Smartphone Apps: The Latest Breakthrough

Table 28. No. of Diabetic Patients Worldwide and No. of App-Using Patients (in Million): 2014 & 2018P (includes corresponding Graph/Chart)

Bar-Illan University of Israel’s Research for Non-invasive, Wearable Glucose Testing Device
Nanotechnology-based Breathalyzer for Non-Invasive Glucose Monitoring
EMG 1000: Needle-free Device for Glucose Monitoring
Glucase: Smartphone Case with Glucose Testing Kit
Painless Diabetes Monitoring Using NFC Technology
GlucoSense: Laser Device for Non-invasive Monitoring of Glucose Levels
ClearPath DS-120: Enabling Early Detection of Diabetes & Prediabetes
Sugar. IQ App: Powerful Features for Diabetics
NoStrip Technology: Eliminating Need for Individual Test Strips
Artificial Pancreas System (APS): The Future of Diabetes Care

5. PRODUCT OVERVIEW

A Prelude
Continuous Glucose Monitoring (CGM) Systems
Hemoglobin A1c (HbA1c) Test
HbA1c Test Types
HbA1c Laboratory Testing
Analytical Techniques Used for Quantifying HbA1c in Labs
Standardization of HbA1c Results

Table 29. CAP Accuracy Grading for HbA1c Measurements (2007-2013)

HbA1c Point of Care Testing & Self-Monitoring
Blood Glucose Testing Devices
Blood Glucose Monitor/Meter
Diabetes Testing Supplies
Blood Glucose Test Strips
Lancet
Lancet Device
Reagent Strips
Reagent Tablet
Diabetes: A Chronic Body Disorder
Diabetes Symptoms
Types of Diabetes
Type I Diabetes: Insulin-Dependent Diabetes Mellitus (IDDM)
Type II Diabetes: Non Insulin-Dependent Diabetes Mellitus (NIDDM)

6. PRODUCT LAUNCHES

Roche Launches Accu-Chek Guide BGM System
Cellnovo Introduces Manual Input Feature to CGM Users
ACON to Offer New Glucose Meter System with On Call Products
Senseonics Receives CE Mark Approval for Eversense CGM System
Ascensia Receives CE Mark Approval for CONTOUR Glucose Monitoring Systems
Intuity Medical Receives FDA Clearance for its POGO System
Medtronic plc Reports Favorable Study Data on its MiniMed Insulin Pump
Nemaura Medical Receives CE Approval for sugarBEAT CGM System
ACON Laboratories Launches OptiLance Push-Button Safety Lancets
LabStyle Innovations Launches Smartphone-powered Glucometer Dario
J&J’s LifeScan Introduces OneTouch Verio System With Easy-to-read Results
Abbott Receives Approval from TGA for FreeStyle Libre System
Dnurse Technology Announces CE Approval for Dnurse Glucose Meter and App
FDA Approves Animas Vibe Insulin Pump and CGM System for Use in Children
Owen Mumford Launches Touch-Activated Lancet Unistik Touch
Dexcom’s G5 Mobile CGM System Receives CE Mark
Dexcom Receives FDA Approval for its G5 Mobile CGM System
Abbott Receives FDA Approval for OTC Glucose Monitor
ARKRAY Unveils New Instruments for HbA1c Measurement
Roche Introduces New Cobas C513 Analyser
ARKRAY Launches B-analyst HbA1c Control for HbA1c Tests
ARKRAY Unveils CinQ HbA1c Range of Reagent Kit
Transasia Bio-Medicals Introduces HbA1c & HbA2/F-Fully Automated Analyzer
ARKRAY Releases PocketChem A1c HbA1c Analyzer
Bio-Rad Bags FDA Approval for D-100 System for A1c Testing
Bio-Rad’s VARIANT II TURBO HbA1c Kit – 2. 0 Receives FDA Approval for Use in Diabetes Diagnosis
Abnova Concludes Clinical Trial for Personal A1c Diabetes Rapid Test
Ortho-Clinical Diagnostics Obtains FDA Approval for VITROS Chemistry Products HbA1c Reagent Kit
FDA Approves Animas Vibe insulin pump and CGM for Adults
CVS/pharmacy Launches its Brand of FDA-Approved Advanced Glucose Meter
Dexcom Receives FDA Approval for Remote Blood Sugar Monitoring Tool
Abbott’s FreeStyle Libre System Receives EU Approval
iHealth Lab Launches iHealth Align
Dexcom Receives FDA Approval for Real-time Professional CGM
Nipro Diagnostics Receives FDA Clearance for TRUE METRIX & TRUE METRIX PRO
LifeScan Launches OneTouch Verio Glucose Monitoring Device
Omnis Health Launches EmbraceEVO Blood Glucose Meter
GE Healthcare Announces Validation of GE200 Blood Glucose Meter
Sanofi Launches Blood Glucose Monitor that Offers HbA1c Estimates
Beckman Coulter Introduces Next-Generation Hemoglobin A1c
ARKRAY Unveils ADAMS A1c mini Glycated- Hemoglobin Analyzer
Axis-Shield Introduces HbA1c Turbidimetric Immunoassay
ARKRAY Unveils ADAMS Hybrid AH-8290 Dual HbA1c and Glucose Analyzer
Sebia Unveils Capillarys HbA1c Assay
Abbott Gains FDA Approval for ARCHITECT Clinical Chemistry HbA1c Test

7. RECENT INDUSTRY ACTIVITY

Ypsomed Collaborates with Novo Nordisk for Insulin Pumps
Senseonics Holdings Signs Exclusive Distribution Agreement with Roche
Siemens Healthcare Rebrands as Siemens Healthineers
Cellnovo and Roche Sign Agreement on Blood Glucose Monitors
Bayer to Sell Diabetes Care Business to Panasonic Healthcare
Sinocare to Acquire PTS Diagnostics
Abbott Inks Definitive Agreement to Take over Alere
Decision Diagnostics Enters into R&D Agreement with Korean Manufacturer
Medtronic Collaborates with Qualcomm for Disposable CGM
Integrity Applications Enters into Distribution Agreements with LifeCaring Technologies and Guangzhou Guang Yuan Biological
Insulet Corporation Extends Agreement with Abbott
Decision Diagnostics Acquires Genstrip from Shasta Technologies

8. FOCUS ON SELECT GLOBAL PLAYERS

Abbott Diabetes Care, Inc. (US)
Acon Laboratories, Inc. (US)
AgaMatrix, Inc. (US)
Alere Inc. (US)
Animas Corporation (US)
Apex Biotechnology Corporation (Taiwan)
ARKRAY, Inc. (Japan)
Ascensia Diabetes Care Holdings AG (Switzerland)
A. Menarini Diagnostics Ltd. (UK)
B. Braun Melsungen AG (Germany)
Becton, Dickinson and Company (US)
Bayer Healthcare Diabetes Care (US)
Beckman Coulter, Inc. (US)
Bio-Rad Laboratories (US)
BIONIME Corporation (Taiwan)
Diazyme Laboratories Inc. (US)
Dexcom, Inc. (US)
EKF Diagnostics Holdings Plc (UK)
HemoCue AB (Sweden)
Infopia Co. , Ltd. (South Korea)
LifeScan, Inc. (US)
Medtronic MiniMed, Inc. (US)
Nova Biomedical Corporation (US)
PTS Diagnostics (US)
Roche Diagnostics (Switzerland)
Sanofi S. A. (France)
Sanwa Kagaku Kenkyusho Co, Ltd. (Japan)
Siemens Healthineers (Germany)
Taidoc Technology Corporation (Taiwan)
Tandem Diabetes Care, Inc. (US)
Terumo Corporation (Japan)
Tosoh Bioscience, Inc. (US)
Trinity Biotech plc (Ireland)
Trividia Health, Inc. (US)
Ypsomed AG (Switzerland)

9. GLOBAL MARKET PERSPECTIVE

Table 30. World Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 31. World Historic Review for Diabetes Diagnostics by Geographic Region/ Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 32. World 14-Year Perspective for Diabetes Diagnostics by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

By Product Segment:

Table 33. World Recent Past, Current & Future Analysis for CGM Systems by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 34. World Historic Review for CGM Systems by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 35. World 14-Year Perspective for CGM Systems by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 36. World Recent Past, Current & Future Analysis for HbA1c Testing Devices by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 37. World Historic Review for HbA1c Testing Devices by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 38. World 14-Year Perspective for HbA1c Testing Devices by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 39. World Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 40. World Historic Review for Blood Glucose Monitoring Devices by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 41. World 14-Year Perspective for Blood Glucose Monitoring Devices by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

A. Market Analysis
The US: The Largest Diabetes Diagnostics Market Worldwide
Diabetes: A Leading Cause of Death in the US

Table 42. Diabetes and Population Statistics in North America and Caribbean Region (2015 & 2040) (includes corresponding Graph/Chart)
Table 43. Diabetes Statistics in the US (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s)

Aging Population: A Key Growth Factor

Table 44. Diabetes Prevalence in the US (2015E): Percentage Share of Number of Diabetics by Gender (includes corresponding Graph/Chart)
Table 45. Diabetes Prevalence in the US (2015E): Percentage Share of Number of Diabetics by Age Group (includes corresponding Graph/Chart)
Table 46. Aging Population in the US (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
Table 47. North American Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)

Economic Burden of Diabetes

Table 48. Health Expenditure (in US$ Billion) on Diabetes in the US: 2015 & 2040 (includes corresponding Graph/Chart)

Healthcare Reform Legislation: Impact on Diabetes Diagnostics
HbA1c Testing for Diabetes Detection Gains Support
ADA Recommends HbA1c Test for Diabetes Diagnosis
ADA Recommends New Guidelines for HbA1c Testing for Certain Patients
HbA1c – Increasingly Moving into Physician’s Office
Study Finds Dentist Visits to be an Opportunity for HbA1c-based Diabetes Screening & Management
Growing Inclination towards CLIA-Waived Tests
Wearable and Non-Invasive Glucose Monitoring Devices Favored
FDA Guidance for Blood Glucose Meters
Emerging 'Grey Market' for Testing Strips
Competitive Landscape
US Near Patient HbA1c Testing: A Highly Consolidated Market

Table 49. Leading Players in the US Near Patient HbA1c Testing Market (2015E): Percentage Share Breakdown of Revenues for Alere, Siemens and Others (includes corresponding Graph/Chart)

CGM Devices: Highly Consolidated Marketplace

Table 50. Leading Companies in the US CGM Market (2014 & 2020P): Percentage Share Breakdown of Revenue for Abbott, DexCom, and Medtronic (includes corresponding Graph/Chart)

Companies Focus on Research for Better Diabetes Diagnostics
Drugstores Benefit from the Diabetic Care Category
Integrated Products: An Upcoming Trend
Product Launches
Strategic Corporate Developments
Select Key Players
B. Market Analytics

Table 51. US Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 52. US Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 53. US 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

2. CANADA

A. Market Analysis
Current & Future Analysis
Diabetes Statistics in Canada: Opportunity Indicator for Diabetes Diagnostics

Table 54. Diabetes Statistics in Canada (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s)
Table 55. Adult Diabetes in Canada (2015E): Percentage Share Breakdown of Diabetic Population by Gender (includes corresponding Graph/Chart)
Table 56. Adult Diabetes in Canada (2015E): Percentage Share Breakdown of Diabetic Population by Age Group (includes corresponding Graph/Chart)

Aging Population: Key Opportunity Indicator

Table 57. Aging Population in Canada (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

B. Market Analytics

Table 58. Canadian Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 59. Canadian Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 60. Canadian 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

3. JAPAN

A. Market Analysis
Growing Aging Population Drives Diabetes Diagnostics Market

Table 61. Aging Population in Japan (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

Trends Influencing Diabetes Diagnostics Market

Table 62. Diabetes Statistics in Japan (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s)

Product Launches
Select Key Players
B. Market Analytics

Table 63. Japanese Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 64. Japanese Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 65. Japanese 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4. EUROPE

A. Market Analysis
Diabetes Diagnostics Market in Europe – A Promising Outlook
Proven Efficacy and Benefits of POCT HbA1C Tests Spur Adoption
Diabetes Statistics in Europe

Table 66. Diabetes and Population Statistics in Europe (2015 & 2040) (includes corresponding Graph/Chart)
Table 67. Diabetes Statistics in Europe (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)

Reimbursement Scenario
Product Launch
B. Market Analytics

Table 68. European Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region/Country - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 69. European Historic Review for Diabetes Diagnostics by Geographic Region/ Country - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 70. European 14-Year Perspective for Diabetes Diagnostics by Geographic Region/Country - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 71. European Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 72. European Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 73. European 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4A. FRANCE

A. Market Analysis
France: Diabetes & Aging Statistics

Table 74. Diabetes Statistics in France (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s)
Table 75. Aging Population in France (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

Product Launches
Strategic Corporate Development
Sanofi S. A. : A Major France-Based Company
B. Market Analytics

Table 76. French Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 77. French Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 78. French 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4B. GERMANY

A. Market Analysis
Germany: Diabetes & Aging Statistics

Table 79. Diabetes Statistics in Germany (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s)
Table 80. Aging Population in Germany (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

Strategic Corporate Developments
Select Key Players
B. Market Analytics

Table 81. German Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 82. German Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 83. German 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4C. ITALY

A. Market Analysis
Italy: Diabetes & Aging Statistics

Table 84. Diabetes Statistics in Italy (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s)
Table 85. Aging Population in Italy (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

B. Market Analytics

Table 86. Italian Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 87. Italian Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 88. Italian 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4D. THE UNITED KINGDOM

A. Market Analysis
NHS England Launches Action for Diabetes Plan
NHS Guidelines for Lancets, Testing Strips, and Meters for Blood Glucose Testing
Self-Monitoring Blood Glucose Meters Gain Popularity
NICE Recommendations for Self-Monitoring Blood Glucose (SMBG)
Diabetes Statistics & Management – An Insight

Table 89. Diabetes Statistics in United Kingdom (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s)
Table 90. Aging Population in the United Kingdom (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

Rising Obesity Cases – Increased Risk of Diabetes
Type 1 Diabetes in Children

Table 91. Number of Children with Type 1 Diabetes in Select Countries (2015) (includes corresponding Graph/Chart)

Product Launches
Select Key Players
B. Market Analytics

Table 92. UK Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 93. UK Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 94. UK 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4E. SPAIN

A. Market Analysis
Spain: Diabetes & Aging Statistics

Table 95. Diabetes Statistics in Spain (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s)
Table 96. Aging Population in Spain (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

B. Market Analytics

Table 97. Spanish Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 98. Spanish Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 99. Spanish 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4F. RUSSIA

A. Market Analysis
Russia: Diabetes & Aging Statistics

Table 100. Diabetes Statistics in Russia (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s)
Table 101. Aging Population in Russia (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

B. Market Analytics

Table 102. Russian Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 103. Russian Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 104. Russian 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4G. REST OF EUROPE

A. Market Analysis
Product Launches
Strategic Corporate Developments
Select Key Players
B. Market Analytics

Table 105. Rest of European Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 106. Rest of European Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 107. Rest of European 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

A. Market Analysis
Technological Integration: An Emerging Trend in the Asia-Pacific Medical Devices Market
Public and Private Sector Diabetes Care
Public Sector
Private Sector
BGM Devices: Competitive Landscape
Rising Diabetes Incidence in Asia-Pacific Offers Significant Growth Opportunities

Table 108. Diabetes and Population Statistics in Western Pacific (2015 & 2040) (includes corresponding Graph/Chart)
Table 109. Diabetes Statistics in Western Pacific (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)
Table 110. Diabetes and Population Statistics in South East Asia (2015 & 2040) (includes corresponding Graph/Chart)
Table 111. Diabetes Statistics in South East Asia (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)

Role of Healthcare Societies and Associations
India
Bangladesh
Western Pacific Declaration on Diabetes
China
China: Lower Penetration Offers High Growth Potential

Table 112. Leading Companies in the Chinese Glucose Meter Market (2015): Percentage Share Breakdown of Revenue for Abbott, Bayer, J&J, Omron, Roche, Sinocare & Yuyue (includes corresponding Graph/Chart)

Reimbursement of Diabetes Diagnostics in China (2015): Glucose Meters and Test Strips’ Reimbursement Status and Percentage
Increasing Diabetes Incidence Remains Growth Driver

Table 113. Diabetes Statistics in China (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s)

Key Opportunity Indicator: Aging Population

Table 114. Aging Population in China (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

India
Market Overview
Growth Stimulants & Challenges in a Nutshell
HbA1c Testing on Growth Spree
Most Glucose Meters in Indian Market Feature Imported Technology
ICMR Develops New Indigenous, Low-Cost Diabetes Detection Technology
Market Restraints
Rising Diabetes Cases – Opportunities for Diabetes Diagnostics

Table 115. Diabetes Statistics in India (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s)

Key Opportunity Indicator: Aging Population

Table 116. Aging Population in India (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

Australia
Australia: An Insight into Diabetes Statistics

Table 117. Diabetes Population in Australia (2015): Percentage Share Breakdown of Number of Diabetics by Age Group (includes corresponding Graph/Chart)
Table 118. Diabetes Statistics in Australia (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s)

Key Opportunity Indicator: Aging Population Statistics in Rest of Asia-Pacific

Table 119. Aging Population in Rest of Asia by Country (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

Product Launches
Select Key Players
B. Market Analytics

Table 120. Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region/Country - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 121. Asia-Pacific Historic Review for Diabetes Diagnostics by Geographic Region/ Country - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 122. Asia-Pacific 14-Year Perspective for Diabetes Diagnostics by Geographic Region/ Country - Percentage Breakdown of Dollar Sales for China, India, and Rest of Asia-Pacific Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 123. Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 124. Asia-Pacific Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 125. Asia-Pacific 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

6. LATIN AMERICA

A. Market Analysis
Diabetes in Latin America – A Glance at Key Statistics

Table 126. Diabetes and Population Statistics in Central and South America (2015 & 2040) (includes corresponding Graph/Chart)
Table 127. Diabetes Statistics in South & Central America (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)

Key Opportunity Indicator: Aging Population

Table 128. Aging Population in Latin America and the Caribbean by Region (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
Table 129. Aging Population in Latin America by Country (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

B. Market Analytics

Table 130. Latin American Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 131. Latin American Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 132. Latin American 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

7. REST OF WORLD

A. Market Analysis
Diabetes Statistics in Africa and the Middle East

Table 133. African Diabetes and Population Statistics (2015 & 2040) (includes corresponding Graph/Chart)
Table 134. Diabetes Statistics in Africa (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)
Table 135. Diabetes and Population Statistics in Middle East and North Africa (2015 & 2040) (includes corresponding Graph/Chart)
Table 136. Diabetes Statistics in Middle East and North Africa (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)

Key Opportunity Indicator: Aging Population

Table 137. Aging Population in the Middle East by Country (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)
Table 138. Aging Population in Africa by Region (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart)

Strategic Corporate Development
Clinical-Stage Company Based in Israel - Integrity Applications
B. Market Analytics

Table 139. Rest of World Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 140. Rest of World Historic Review for Diabetes Diagnostics by Product Segment - CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 141. Rest of World 14-Year Perspective for Diabetes Diagnostics by Product Segment - Percentage Breakdown of Dollar Sales for CGM Systems, HbA1c Testing Devices, and Blood Glucose Monitoring Devices Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 58 (including Divisions/Subsidiaries - 75)
The United States (35)
Canada (1)
Japan (4)
Europe (23)
  France (2)
  Germany (4)
  The United Kingdom (8)
  Italy (1)
  Rest of Europe (8)
Asia-Pacific (Excluding Japan) (10)
Middle-East (2)
Skip to top


Ask Your Question

Diabetes Diagnostics: Market Research Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: